Table 3.
Thiamine Intake, mg/day | N | Cases (Incidence Rate †) |
Crude Model | Adjusted Model * | ||
---|---|---|---|---|---|---|
HR (95% CI) | p Value | HR (95% CI) | p Value | |||
Quartiles | ||||||
Q1 (<0.76) | 3044 | 977 (53.1) | ref | ref | ||
Q2 (0.76–<0.93) | 3044 | 981 (38.3) | 0.70 (0.64, 0.77) | <0.001 | 0.82 (0.74, 0.90) | <0.001 |
Q3 (0.93–<1.13) | 3044 | 1004 (36.8) | 0.67 (0.62, 0.74) | <0.001 | 0.78 (0.70, 0.87) | <0.001 |
Q4 (≥1.13) | 3045 | 1307 (54.9) | 1.02 (0.94, 1.10) | 0.702 | 1.08 (0.95, 1.22) | 0.229 |
Categories | ||||||
Q1 (<0.76) | 3044 | 977 (53.1) | 1.45 (1.35, 1.57) | <0.001 | 1.25 (1.14, 1.37) | <0.001 |
Q2–3 (0.76–<1.13) | 6088 | 1985 (37.5) | ref | ref | ||
Q4 (≥1.13) | 3045 | 1307 (54.9) | 1.48 (1.38, 1.58) | <0.001 | 1.36 (1.25, 1.47) | <0.001 |
* Adjusted for sex, age, body mass index, survey year, regions, SBP, DBP, alcohol drinking, smoking, urban or rural residents, education levels, occupations, physical activity, intakes of energy, sodium and potassium. † Incidence rate of hypertension was calculated as the number of new-onset cases of hypertension divided by person-years of follow-up and was expressed per 1000 person-years.